Therapeutic Advances in Ocular Disease 2025

Dr. Ron Melton has lectured nationally and internationally at over 1,000 continuing medical education meetings with the goal of educating optometrists around the world about ocular disease. He was recognized as one of the top 150 optometrists in the U.S. by Newsweek’s “America’s Best Optometrists Award” in 2021 and 2022.  He was honored as a co-recipient of the “Pioneer in Optometry” recognition by the Editorial Board of Primary Care Optometry News in April 2015 for contributions to optometry education.   Dr. Melton was named co-recipient of the American Academy of Optometry 2014 Vincent Ellerbrock Clinician Educator Award for outstanding and sustained contributions to the Academy’s Lectures and Workshops program.  He sits on the editorial advisory board of the Review of Optometry.  Dr. Melton has authored or co-authored over 100 papers on optometry and is the co-author of the popular annual “Clinical Guide to Ophthalmic Drugs” for Review of Optometry”, now in its twenty-seventh year.  Dr. Melton has acted as an investigator in more than 50 clinical research trials.  Currently, he is a member of the adjunct faculty at Salus University (Pennsylvania College of Optometry) and Indiana University (School of Optometry).   He is certified as a Diplomate with the American Board of Optometry.  He is in a group practice in Charlotte, North Carolina, where he has staff privileges at Novant Health Presbyterian Medical Center.